On December 29, 2023, SomaLogic Inc announced that independent proxy advisory firm Glass Lewis & Co has recommended the stockholders to vote for the pending merger with Standard BioTools at the company?s Special Meeting of Stockholders to be held on January 4, 2024, together with the recommendation previously made by Institutional Shareholder Services on December 22, 2023, both independent proxy advisory firms have recommended the stockholders vote for the merger transaction. In addition, the Company board recommended the shareholders to vote for each of the proposals related to the transaction at the Special Meeting of Stockholders.